Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-065696)

Filing Details

Accession Number:: 0001209191-21-065696
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-19 07:30:28
Reporting Period:: 2021-11-17

Accepted Time:: 2021-11-19 07:30:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1579428	Axsome Therapeutics Inc.	AXSM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295913	E Mark Saad	C/O Axsome Therapeutics, Inc. 22 Cortlandt Street, 16Th Floor New York NY 10007		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-17	3,000	$34.53	10,002	No	4	P	Direct
Common Stock	Acquisiton	2021-11-17	100	$34.40	100	No	4	P	Indirect	Custodial account for child
Common Stock	Acquisiton	2021-11-17	100	$34.45	100	No	4	P	Indirect	Custodial account for child
Common Stock	Acquisiton	2021-11-17	100	$34.40	100	No	4	P	Indirect	Custodial account for child

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	Custodial account for child
No	4	P	Indirect	Custodial account for child
No	4	P	Indirect	Custodial account for child

Footnotes

These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.